N/A
Completed N=16
Feasibility Study Evaluating the ParaPatch System
Source: ClinicalTrials.gov NCT02278146 ↗Enrolled (actual)
16
Serious AEs
0.0%
Results posted
Jan 2017
Primary outcomePrimary: Number of Participants Who Used the ParaPatch System With Adverse Events Through the Completion of the Study — 8; 6 participants
Summary
A multi-center, open-label, prospective, feasibility study evaluating the ParaPatch System for the treatment of urinary incontinence and overactive bladder.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Who Used the ParaPatch System With Adverse Events Through the Completion of the Study |
8; 6 | — |
| SECONDARY Stress Incontinence Arm |
83; 75 | — |
| SECONDARY Overactive Bladder Arm |
83; 75 | — |
Eligibility Criteria
Inclusion Criteria
- Women aged from >18 to 2 times within the past 6 months).
- Have neurogenic disorders such as Multiple Sclerosis, ALS, or Parkinson s Disease.
- Patients with a diagnosis of painful bladder syndrome, other pelvic pain or interstitial cystitis.
Data sourced from ClinicalTrials.gov (NCT02278146). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.